Literature DB >> 2626213

Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation.

R C Wiggins1, C Rolsten, B Ruiz, C M Davis.   

Abstract

As a preface to the pharmacokinetic analysis of cocaine in pregnant and lactating rats (using oral administration of drug), young Long-Evans rats were used to compare the relative concentrations of cocaine in blood, brain, and liver after administering cocaine by iv or oral routes. Cocaine and its metabolites were determined using 3H-cocaine as a tracer, followed by homogenization and solvent extraction of tissues, and quantitative analysis by HPTLC and LSC. From 30 min postinjection to several hrs later, the concentration of cocaine was higher in brain (3-4 fold) and liver (3-5 fold) than in blood, using the iv route. Using the oral route, the concentration in brain was 2-3 fold higher than in blood, and in liver, 10-20 fold higher. The metabolites of cocaine were largely excluded from entry into brain tissue, whereas the accumulation of metabolites in liver was typically an order of magnitude higher, or more, than in blood (iv or oral route). The ratio of cocaine to metabolites increased in all three tissues, as the dosage increased, indicating that more and more of an administered dose actually reaches the tissues as cocaine as the dosage level increases. During the period from 30 to 90 min following the administration of cocaine to pregnant dams, cocaine appeared in fetal brain at a rate of 50-90% of the concentration in the dam's brain (presumably because of the lower lipid content in fetal brain compared to adult), but still at a rate of 109-151% of the concentration in the dam's blood. Cocaine is sufficiently stable in milk to assume that any cocaine entering breast milk from the blood stream will be available to the suckling infant, and after administering radioactive cocaine to lactating dams, the milk/blood ratio for cocaine averaged 7.8. These data indicate that both the fetus and suckling infant are at considerable risk from cocaine use by the mother.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626213

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  10 in total

1.  Plasma cocaine levels, metabolites, and locomotor activity after subcutaneous cocaine injection are stable across the postpartum period in rats.

Authors:  Michael P Wansaw; Shen-Nan Lin; Joan I Morrell
Journal:  Pharmacol Biochem Behav       Date:  2005-08-22       Impact factor: 3.533

Review 2.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

3.  Development under the influence of cocaine. II. Comparison of the effects of maternal cocaine and associated undernutrition on brain myelin development in the offspring.

Authors:  R C Wiggins; B Ruiz
Journal:  Metab Brain Dis       Date:  1990-06       Impact factor: 3.584

4.  Functional consequences of acute cocaine treatment depend on route of administration.

Authors:  L J Porrino
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Development under the influence of cocaine. I. A comparison of the effects of daily cocaine treatment and resultant undernutrition on pregnancy and early growth in a large population of rats.

Authors:  R C Wiggins; B Ruiz
Journal:  Metab Brain Dis       Date:  1990-06       Impact factor: 3.584

6.  Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans.

Authors:  C M Heesch; C R Wilhelm; J Ristich; J Adnane; F A Bontempo; W R Wagner
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

7.  Maternal cocaine use during breastfeeding.

Authors:  Alex M Cressman; Gideon Koren; Anna Pupco; Eunji Kim; Shinya Ito; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-11       Impact factor: 3.275

8.  Cocaine differentially inhibits neuronal differentiation and proliferation in vitro.

Authors:  D Zachor; J K Cherkes; C T Fay; I Ocrant
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  A mechanism for the inhibition of neural progenitor cell proliferation by cocaine.

Authors:  Chun-Ting Lee; Jia Chen; Teruo Hayashi; Shang-Yi Tsai; Joseph F Sanchez; Stacie L Errico; Rose Amable; Tsung-Ping Su; Ross H Lowe; Marilyn A Huestis; James Shen; Kevin G Becker; Herbert M Geller; William J Freed
Journal:  PLoS Med       Date:  2008-06-10       Impact factor: 11.069

10.  Influence of the dopaminergic system, CREB, and transcription factor-κB on cocaine neurotoxicity.

Authors:  C S Planeta; L B Lepsch; R Alves; C Scavone
Journal:  Braz J Med Biol Res       Date:  2013-10-15       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.